Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:06 pm Purchase | 13G | Old Ayala Inc ADXS | Redmile Group LLC | 667,816 5.2% | 667,816 (New Position) | View |
| 2021-02-16 4:06 pm Purchase | 13G | AVITA MEDICAL INC RCEL | Redmile Group LLC | 1,707,386 7.9% | 1,707,386 (New Position) | View |
| 2021-02-16 4:06 pm Purchase | 13G | Atreca Inc. BCEL | Redmile Group LLC | 2,476,068 8.26% | 1,339,262 (+117.81%) | View |
| 2021-02-16 4:06 pm Sale | 13G | Aprea Therapeutics Inc. APRE | Redmile Group LLC | 1,268,718 5.99% | -1,000,000 (-44.08%) | View |
| 2021-02-16 4:06 pm Purchase | 13G | Annexon Inc. ANNX | Redmile Group LLC | 3,448,030 9.04% | 3,448,030 (New Position) | View |
| 2021-02-16 4:06 pm Sale | 13G | AMICUS THERAPEUTICS INC. FOLD | Redmile Group LLC | 22,125,489 8.5% | -3,357,280 (-13.17%) | View |
| 2021-02-16 4:06 pm Sale | 13G | ALLAKOS INC ALLK | Redmile Group LLC | 2,667,451 5.08% | -366,075 (-12.07%) | View |
| 2021-02-16 4:05 pm Purchase | 13G | Akero Therapeutics Inc. AKRO | Redmile Group LLC | 2,322,557 6.69% | 2,322,557 (New Position) | View |
| 2021-02-16 4:05 pm Purchase | 13G | ADC Therapeutics SA ADCT | Redmile Group LLC | 6,758,794 8.81% | 6,758,794 (New Position) | View |
| 2021-01-12 4:18 pm Purchase | 13D | FATE THERAPEUTICS INC FATE | Redmile Group LLC | 12,993,888 14.1% | 332,152 (+2.62%) | View |
| 2020-12-15 4:14 pm Purchase | 13D | IGM Biosciences Inc. IGMS | Redmile Group LLC | 3,438,032 13.5% | 8,216 (+0.24%) | View |
| 2020-11-27 4:02 pm Purchase | 13D | MEDAVAIL HLDGS INC MDVLQ | Redmile Group LLC | 12,029,652 37.6% | 12,029,652 (New Position) | View |
| 2020-10-15 5:23 pm Purchase | 13D | Shattuck Labs Inc. STTK | Redmile Group LLC | 5,619,914 13.5% | 5,619,914 (New Position) | View |
| 2020-10-15 4:08 pm Purchase | 13D | Augmedix Inc. AUGX | Redmile Group LLC | 14,246,125 51.6% | 14,246,125 (New Position) | View |
| 2020-09-09 8:29 pm Purchase | 13D | IGM Biosciences Inc. IGMS | Redmile Group LLC | 3,429,816 14.2% | 285,816 (+9.09%) | View |
| 2020-06-17 8:26 pm Purchase | 13D | FATE THERAPEUTICS INC FATE | Redmile Group LLC | 12,661,736 14.9% | 1,434,928 (+12.78%) | View |
| 2020-06-09 4:18 pm Purchase | 13G | PLIANT THERAPEUTICS INC. PLRX | Redmile Group LLC | 3,410,657 9.6% | 3,410,657 (New Position) | View |
| 2020-02-14 4:26 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Redmile Group LLC | 5,494,109 9.9% | 1,079,492 (+24.45%) | View |
| 2020-02-14 4:26 pm Sale | 13G | eHealth Inc. EHTH | Redmile Group LLC | 0 0% | -1,091,395 (Position Closed) | View |
| 2020-02-14 4:26 pm Purchase | 13G | Epizyme Inc. EPZM | Redmile Group LLC | 9,137,373 9.9% | 2,500,095 (+37.67%) | View |